Promega is launching a post-doctoral research program for life science researchers to explore new ideas for genome engineering technology, the company announced today. AstraZeneca will provide mentoring support in the three-year…

Promega has entered a non-exclusive license agreement with the Broad Institute of MIT and Harvard to sell tools and reagents for CRISPR-Cas9 gene editing, the company announced today. “With this combination…